A Food and Drug Administration panel will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.
The FDA on Wednesday posted much of the evidence its advisory panel will consider Friday.
The agency struck a decidedly neutral tone on the rationale for boosters — an unusual and careful approach that’s all the more striking after President Joe Biden and his top health advisers trumpeted a booster campaign they hoped to begin by late September.
FDA panel to vote on Pfizer booster shot
"Wrinkles The Clown" sends recorded message to PIX11's Watch with Dan documentary club
Actor Julian Lerner goes back in time for 'The Wonder Years'
Country singer Jennifer Nettles joins 'Waitress' on Broadway
Singer N'Kenge stars in Broadway's 'Caroline, or Change'
Public advocate outlines plan to fix NYC's flooding issue
Fall nor’easter: How are the subways holding up?
Fall nor'easter: Heavy rain, gusty winds
MTA prepared for fall nor'easter, working to prevent flooding
New York under state of emergency as nor'easter brings heavy rain
Weather alert: Fall nor'easter brings heavy rain, wind to NY, NJ
Weather alert: Fall nor'easter brings heavy downpours, winds to NY, NJ
Weather alert: Fall nor'easter brings heavy rain, winds to NY, NJ